Novo Nordisk Launches Digital Health Ecosystem Alliance for Integrated Diabetes Management

——Driving Change through Digital Health Solutions

ShanghaiNovember 7, 2023PR Newswire -- On November 6, during the Sixth China International Import Expo, Novo Nordisk, a world-leading biopharmaceutical company, joined hands with numerous partners in the health ecosystem to hold the inauguration ceremony for the establishment of the Digital Health Ecosystem Partnership Alliance. This initiative aims to build an open digital ecosystem alliance, inviting industry chain partners from treatment areas related to diabetes, rare diseases, and obesity, among others, to collectively invest resources and explore future patient-centered digital solutions. Corporate representatives from Sinopharm Holding, Ping An Health, iFlytek Healthcare, Silicon Life, Sinocare, Tanghu Technology, and Lifescan attended the event.

Launch Ceremony of Novo Nordisk Digital Health Ecosystem Partnership Alliance

Facing the rapid development of global digital technology, digital innovation is also a breakthrough for Novo Nordisk to further meet patient needs and help patients benefit. Novo Nordisk hopes to join hands with local forces in China, complement each other's strengths, and "drive change through digital health solutions" to fully connect the diabetes digital management chain from "disease management, drug delivery, medication use to long-term management." Centered around "medication + services," Novo Nordisk aims to create the best post-medication experience for patients, promoting chronic disease management from "emphasizing treatment over management" to "equal focus on treatment and management." This will help patients overcome various obstacles to achieve "effortless diabetes management" and take control of their lives.

What we shorten is not only distance, but also time.

Novo Nordisk collaborates with Ping An Health to establish a new specialized diabetes management center within an internet hospital. Leveraging Novo Nordisk's extensive experience in the diabetes field and relying on Ping An Health’s expertise in operating and managing internet hospital platforms, the center provides patients with a full-process service platform to support convenient and efficient disease management.

Through the Specialized Diabetes Management Center of Internet Hospitals, a convenient communication bridge is built between doctors and patients, allowing patients to enjoy convenient services such as health assessment, consultation, diagnosis, medication purchase, and follow-up without leaving their homes. This saves precious time during the medical journey, helps diabetes patients, especially those in remote areas and elderly patients, avoid delays in blood glucose management due to spatiotemporal difficulties in accessing healthcare, and enhances medical accessibility.

Ensure every hypoglycemic medication is safely delivered to your home.

Main injectable drugs for blood sugar control in diabetic patients, such as insulin and GLP-1, must be transported entirely through a cold chain with strict temperature requirements. Any excessively high or low temperatures during transportation and storage can affect the efficacy of insulin. Sinopharm Holding Corp., Ltd. is not only the largest distributor of pharmaceuticals and healthcare products in China but also a leading supply chain service provider, owning and operating the largest pharmaceutical distribution network in the country. The collaboration between Novo Nordisk and Sinopharm aims to promote the cold chain distribution of innovative drugs, addressing the "last mile" challenge of delivering insulin to diabetic patients at home.

Intelligent Care Experience Center

Answer patients' health questions anytime, anywhere

"Little Nuo Teacher" is an intelligent AI Q&A robot developed by Novo Nordisk. It has already assisted nearly 30,000 patients and answered over 400,000 patient inquiries. This time, iFlytek Healthcare is providing technical support to Novo Nordisk for the creation of "Little Nuo Teacher 2.0," utilizing artificial intelligence technology to offer extended applications in multiple scenarios, including intelligent customer service and digital humans, helping patients access disease management knowledge anytime and anywhere. "Little Nuo Teacher" will become every diabetes patient's "AI Health Knowledge Assistant," answering health-related questions at any time, ensuring patients are not hindered by complex disease management knowledge and can easily address blood sugar control challenges.

Make Home Health Management Easy and Intelligent

Starting from the daily management needs of patients with diseases, and with digital technology and smart devices at its core, Novo Nordisk has collaborated with well-known blood glucose monitoring device brands in and outside of China—such as Silicon Bioelectronics, Sinocare, Tanghu Technology, and LifeScan—to independently develop a one-stop intelligent diabetes self-management solution: the NovoCare mobile application (APP). The app will be gradually available on major mobile app stores starting from November, offering free downloads for patients using Novo Nordisk products.Use。

The NovoCare APP integrates cutting-edge technology, smart devices, health data, and professional knowledge, presenting four key data sets on a single screen: blood glucose monitoring, insulin medication, physical activity, and dietary intake, allowing patients to manage all aspects in one place. By connecting software and hardware, the platform helps diabetes patients better understand personalized characteristics of their blood glucose fluctuations, simplifies long-term management, effectively enhances patient compliance, and improves blood glucose control.

Intelligent Care Experience Center

Xiaoping Zhou, Global Senior Vice President of Novo Nordisk and President of Greater ChinaSaid: "China has become a global innovation leader in digital technology. Novo Nordisk, starting from the needs of patients, is leading digital innovation breakthroughs in the field of diabetes and other serious chronic diseases. We hope to leverage the strong cooperative magnetism of the CIIE, starting with the Digital Health Ecosystem Partnership Alliance, to co-create and share with more local innovative companies, and develop China-customized, globally leading digital health solutions to help patients enjoy a higher quality of life."